Abirateron MSN 500 mg filmom obložene tablete
| Name | Abirateron MSN 500 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-486447750 |
| Active Substance | abirateronacetat |
| Composition | jedna filmom obložena tableta sadrži 500 mg abirateronacetata, što odgovara 446 mg abiraterona |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | MSN Labs Europe Limited, Paola, Malta
Pharmadox Healthcare Limited, Paola, Malta |
| Marketing Authorisation Holder | MSN Labs Europe Limited, Kw20a Corradino Park, Paola, Malta |
| Marketing Authorisation Date | 18.12.2024 |
| MA Period of Validity | 18.12.2029 |
| Classification Number | UP/I-530-09/23-01/216 |
| Registration Number | 381-12-01/70-24-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L02BX03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |